Cargando…

Expression and clinical significance of CXCR5/CXCL13 in human non-small cell lung carcinoma

CXCR5 and/or CXCL13 expression is elevated in certain carcinomas and lymphomas. To determine if these factors are involved in progression of non-small cell lung cancer (LuCa), we evaluated their expression in patients with various forms of this disease. Lung biopsies from patients with non-neoplasti...

Descripción completa

Detalles Bibliográficos
Autores principales:	SINGH, RAJESH, GUPTA, PRANAV, KLOECKER, GOETZ H., SINGH, SHAILESH, LILLARD, JAMES W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215579/ https://www.ncbi.nlm.nih.gov/pubmed/25271023 http://dx.doi.org/10.3892/ijo.2014.2688

Ejemplares similares

CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases
por: Mir, Hina, et al.
Publicado: (2015)

CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis
por: Gupta, Pranav, et al.
Publicado: (2014)

CXCL10(+ )T cells and NK cells assist in the recruitment and activation of CXCR3(+ )and CXCL11(+ )leukocytes during Mycobacteria-enhanced colitis
por: Singh, Udai P, et al.
Publicado: (2008)

Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5
por: El-Haibi, Christelle P, et al.
Publicado: (2013)

CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and α(v)β(3) integrin clustering
por: Singh, Rajesh, et al.
Publicado: (2016)

Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation
por: Mir, Hina, et al.
Publicado: (2019)

Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment
por: Ohandjo, Adaugo Q., et al.
Publicado: (2019)

PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells
por: El Haibi, Christelle P, et al.
Publicado: (2010)

Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
por: Pan, Zijian, et al.
Publicado: (2022)

CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling
por: Mir, Hina, et al.
Publicado: (2021)

Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment
por: Tan, Ping, et al.
Publicado: (2018)

Corrigendum: Role of the CXCL13/CXCR5 axis in autoimmune diseases
por: Pan, Zijian, et al.
Publicado: (2022)

The clinical significance of CXCL5 in non-small cell lung cancer
por: Wu, Kongju, et al.
Publicado: (2017)

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF
por: Harrer, Christine, et al.
Publicado: (2021)

CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE
por: Da, Zhanyun, et al.
Publicado: (2016)

CXCL10 blockade protects mice from cyclophosphamide-induced cystitis
por: Sakthivel, Senthilkumar K, et al.
Publicado: (2008)

CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
por: Cavallaro, Sebastiano
Publicado: (2013)

CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
por: Kazanietz, Marcelo G., et al.
Publicado: (2019)

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma
por: Kasashima, Hiroaki, et al.
Publicado: (2017)

Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
por: Bhandari, Shruti, et al.
Publicado: (2021)

CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)

Immunohistochemical Expression of Chemokine Receptor CXCR3 and its Ligand CXCL 11 in Basal Cell Carcinoma
por: Ansari, Mariya K., et al.
Publicado: (2023)

CXCL13/CXCR5 Interaction Facilitates VCAM-1-Dependent Migration in Human Osteosarcoma
por: Liu, Ju-Fang, et al.
Publicado: (2020)

CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis
por: Trolese, Maria Chiara, et al.
Publicado: (2020)

Linking neuroinflammation to motor neuron degeneration in ALS: The critical role of CXCL13/CXCR5
por: ARNOUX, Alizée, et al.
Publicado: (2020)

Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer
por: Hsieh, Ching-Hung, et al.
Publicado: (2022)

The Significance of CXCL1 and CXCR1 as Potential Biomarkers of Colorectal Cancer
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2023)

Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's Lymphoma
por: Widney, Daniel P., et al.
Publicado: (2010)

Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin's lymphoma
por: Widney, DP, et al.
Publicado: (2009)

Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
por: Guo, Li, et al.
Publicado: (2011)

Clinicopathologic Significance of CXCL12 and CXCR4 Expressions in Patients with Colorectal Cancer
por: Yoshuantari, Naomi, et al.
Publicado: (2018)

CXCL12-CXCR4 axis in feline mammary carcinoma
por: Ferreira, Fernando
Publicado: (2017)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
por: Zhou, Xiao-ming, et al.
Publicado: (2015)

Expression of CXCL12-CXCR4/CXCR7 chemokines in splenic fibrosis of cirrhotic spleen and its therapeutic significance
por: Lv, Yunfu, et al.
Publicado: (2023)

The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation
por: Harrer, Christine, et al.
Publicado: (2022)

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010)

CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
por: Werner, Thomas A, et al.
Publicado: (2017)

CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
por: Wald, Ori, et al.
Publicado: (2013)

Association between CXCL16/CXCR6 expression and the clinicopathological features of patients with non-small cell lung cancer
por: Ke, Chuangwu, et al.
Publicado: (2017)

Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond
por: Kanaan, Zeyad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9u3uc3pu7gdqissv17ofcbc6on